-
{{ listItem.name }}快速筛选药品，用摩熵药筛
微信扫一扫-立即使用
-
产品立项评估及管线规划
-
数据定制服务
-
产业/行业调研
-
市场洞察咨询服务
-
报告大厅
已收录 68518 份 -
摩熵说直播
最新改良型新药及创新药立项开发
- GLP-1
Best Practice Guide for sponsors of multinational clinical trials with different protocol versions approved in different Member States under the Directive 2001/20/EC that will transition to the Regulation (EU) No. 536/2014
2023-06-12
/
指导原则
欧盟
现行有效
/
欧盟药品注册（HMA）
最新政策法规资讯
-
-
-
政策法规解析 创新药临床审批 政策变动 采集意见
药通社2025-06-17
-
医药器械 政策解析 采集 市场分析
摩熵医械2025-06-03
-
政策解析 宠物医疗 驱虫药
药融圈2025-05-29
-
医保局 政策法规 三类医用耗材 采购新规
摩熵器械2025-05-28
-
FDA 临床试验 CGT 药物审评审批 法案
生物药大时代2025-05-19
-
国家药品集采 政策 药企 药品信息变更
药通社2025-02-20
-
医用耗材 医用耗材集采 集采新规
tyc7111cc太阳成集团2025-01-08
-
医保 医疗保障工作 医保改革
tyc7111cc太阳成集团2024-12-17
最新指导原则
-
关于征集<中心静脉导管产品注册技术审查指导原则(2025年修订版)>修订工作参与企业及单位信息的通知
2025-05-30
-
市场监管总局关于发布<特定全营养配方食品临床试验技术指导原则 肝病>等文件的公告
2025-05-26
-
国家药监局药审中心关于发布<阿尔茨海默病药物临床试验技术指导原则(试行)>的通告(2025年第19号)
2025-05-22
-
zonisamide(唑尼沙胺-be指导原则)
2025-05-20
-
migalastat hydrochloride(盐酸米加司他-be指导原则)
2025-05-20
-
ceftobiprole medocaril sodium(头孢比罗酯钠-be指导原则)
2025-05-20
-
daridorexant(奈莫雷生-be指导原则)
2025-05-20
-
epinephrine(肾上腺素-be指导原则)
2025-05-20
-
metformin hydrochloride(盐酸二甲双胍-be指导原则)
2025-05-20
-
zilucoplan sodium
2025-05-20
-
deutetrabenazine(氘丁苯那嗪-be指导原则)
2025-05-20
-
terbinafine(特比萘芬-be指导原则)
2025-05-20
-
etrasimod arginine(依曲莫德-be指导原则)
2025-05-20
-
国家药监局器审中心关于发布移动医疗器械注册审查指导原则(2025年修订版)的通告(2025年第9号)
2025-05-07
-
关于发布2025年度医疗器械注册审查指导原则编制计划的通告(2025年第10号)
2025-05-07
同部门最新指导原则
-
Veterinary Vaccines EU-SRS User Guide Guidance on the naming and building of veterinary vaccine substance records in EU-SRS
2024-06-30
-
Polymers EU-SRS User Guide Guidance on naming and building polymer records in EU-SRS
2024-06-28
-
Mixtures EU-SRS User Guide Guidance on naming and building mixture records in EU-SRS
2024-06-28
-
Proteins EU-SRS User Guide Guidance on naming and building protein records in EU-SRS
2024-06-24
-
116th Heads of Medicines Agencies Meeting
2024-04-19
-
CTCG Best Practice Guide for sponsors of multinational clinical trials with different Part I document versions approved in different Member States under the Directive 2001/20/EC that will transition to the Regulation (EU) No. 536/2014
2024-03-07
-
115th Heads of Medicines Agencies Meeting
2024-01-24
-
EU-Innovation Network Workplan 2024
2024-01-17
-
The following information should be provided in the cover letter of applications for transitioning a Clinical Trial authorised under the Directive 2001/20/EC to the Clinical Trial Regulation
2023-06-27
-
Joint HMA-EMA Big Data Steering Group
2023-06-12
-
Best Practice Guide for sponsors of multinational clinical trials with different protocol versions approved in different Member States under the Directive 2001/20/EC that will transition to the Regulation (EU) No. 536/2014
2023-06-12
-
Meeting of the Homeopathic Medicinal Products Working Group (HMPWG) In person meeting 27-28 October 2022 Rome, Italy
2023-03-27
-
HMA Core Group for medical devices Statement on effective application of the EU regulatory system for medical devices
2022-12-07
-
Good practice guidance for patient and healthcare professional organisations on the prevention of shortages of medicines for human use
2022-05-13
-
CTCG recommendation to sponsors on managing the impact of the war in Ukraine on clinical trials
2022-04-04
同地域最新指导原则
-
Veterinary Vaccines EU-SRS User Guide Guidance on the naming and building of veterinary vaccine substance records in EU-SRS
2024-06-30
-
Polymers EU-SRS User Guide Guidance on naming and building polymer records in EU-SRS
2024-06-28
-
Mixtures EU-SRS User Guide Guidance on naming and building mixture records in EU-SRS
2024-06-28
-
Proteins EU-SRS User Guide Guidance on naming and building protein records in EU-SRS
2024-06-24
-
116th Heads of Medicines Agencies Meeting
2024-04-19
-
CTCG Best Practice Guide for sponsors of multinational clinical trials with different Part I document versions approved in different Member States under the Directive 2001/20/EC that will transition to the Regulation (EU) No. 536/2014
2024-03-07
-
115th Heads of Medicines Agencies Meeting
2024-01-24
-
EU-Innovation Network Workplan 2024
2024-01-17
-
The following information should be provided in the cover letter of applications for transitioning a Clinical Trial authorised under the Directive 2001/20/EC to the Clinical Trial Regulation
2023-06-27
-
Joint HMA-EMA Big Data Steering Group
2023-06-12
-
Best Practice Guide for sponsors of multinational clinical trials with different protocol versions approved in different Member States under the Directive 2001/20/EC that will transition to the Regulation (EU) No. 536/2014
2023-06-12
-
Meeting of the Homeopathic Medicinal Products Working Group (HMPWG) In person meeting 27-28 October 2022 Rome, Italy
2023-03-27
-
HMA Core Group for medical devices Statement on effective application of the EU regulatory system for medical devices
2022-12-07
-
Good practice guidance for patient and healthcare professional organisations on the prevention of shortages of medicines for human use
2022-05-13
-
CTCG recommendation to sponsors on managing the impact of the war in Ukraine on clinical trials
2022-04-04
18983288589（微信同号）
18983288589（微信同号）
18908392210（微信同号）
18980413049
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: tyc7111cc太阳成集团 tyc7111cc太阳成集团企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网